Aroa Biosurgery Limited Price Chart
Aroa Biosurgery Limited ARX.XA Financial and Trading Overview
| Aroa Biosurgery Limited stock price | 0.59 AUD |
| Previous Close | 0.89 AUD |
| Open | 0.86 AUD |
| Bid | 0.86 AUD x N/A |
| Ask | 0.9 AUD x N/A |
| Day's Range | 0.86 - 0.9 AUD |
| 52 Week Range | 0.63 - 1.25 AUD |
| Volume | 11.86K AUD |
| Avg. Volume | 0 AUD |
| Market Cap | N/A |
| Beta (5Y Monthly) | 0.728183 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.061 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ARX.XA Valuation Measures
| Enterprise Value | 266.54M AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.996633 |
| Enterprise Value/Revenue | 4.207 |
| Enterprise Value/EBITDA | -3173.1 |
Trading Information
Aroa Biosurgery Limited Stock Price History
| Beta (5Y Monthly) | 0.728183 |
| 52-Week Change | 28.98% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.25 AUD |
| 52 Week Low | 0.63 AUD |
| 50-Day Moving Average | 0.99 AUD |
| 200-Day Moving Average | 0.97 AUD |
ARX.XA Share Statistics
| Avg. Volume (3 month) | 0 AUD |
| Avg. Daily Volume (10-Days) | 0 AUD |
| Shares Outstanding | N/A |
| Float | 251.21M |
| Short Ratio | N/A |
| % Held by Insiders | 26.73% |
| % Held by Institutions | 15.10% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | -0.62% |
| Operating Margin (ttm) | -4.90% |
| Gross Margin | 84.40% |
| EBITDA Margin | -0.13% |
Management Effectiveness
| Return on Assets (ttm) | -1.69% |
| Return on Equity (ttm) | -0.39% |
Income Statement
| Revenue (ttm) | 63.36M AUD |
| Revenue Per Share (ttm) | 0.19 AUD |
| Quarterly Revenue Growth (yoy) | 55.90% |
| Gross Profit (ttm) | N/A |
| EBITDA | -84000 AUD |
| Net Income Avi to Common (ttm) | -396000 AUD |
| Diluted EPS (ttm) | -0.061 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 45.93M AUD |
| Total Cash Per Share (mrq) | 0.13 AUD |
| Total Debt (mrq) | 7.11M AUD |
| Total Debt/Equity (mrq) | 6.98 AUD |
| Current Ratio (mrq) | 9.877 |
| Book Value Per Share (mrq) | 0.297 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -3772000 AUD |
| Levered Free Cash Flow (ttm) | -11875625 AUD |
Profile of Aroa Biosurgery Limited
| Country | Australia |
| State | N/A |
| City | Auckland |
| Address | 64 Richard Pearse Drive |
| ZIP | 2022 |
| Phone | 64 9 869 3035 |
| Website | https://aroabio.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | N/A |
Aroa Biosurgery Limited, a regenerative medicine company, engages in the developing, manufacturing, and sells medical devices for wound and tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobia Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds; Myriad Morcells, a morcellized (powdered) format of Myriad Matrix for soft tissue repair and complex wounds; and Reinforced Bioscaffolds, a surgical product for use in ventral hernia repair and abdominal wall reconstruction. The company was incorporated in 2007 and is headquartered in Auckland, New Zealand.
Q&A For Aroa Biosurgery Limited Stock
What is a current ARX.XA stock price?
Aroa Biosurgery Limited ARX.XA stock price today per share is 0.59 AUD.
How to purchase Aroa Biosurgery Limited stock?
You can buy ARX.XA shares on the Cboe AU exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Aroa Biosurgery Limited?
The stock symbol or ticker of Aroa Biosurgery Limited is ARX.XA.
How many shares does Aroa Biosurgery Limited have in circulation?
The max supply of Aroa Biosurgery Limited shares is 0.
What is Aroa Biosurgery Limited Price to Earnings Ratio (PE Ratio)?
Aroa Biosurgery Limited PE Ratio is now.
What was Aroa Biosurgery Limited earnings per share over the trailing 12 months (TTM)?
Aroa Biosurgery Limited EPS is -0.061 AUD over the trailing 12 months.